[89Zr]Zr-BI 754111

N/A

Report date: 2026/03/23 20:03:44

Base Information

Drug Name[89Zr]Zr-BI 754111

Drug Alias Name[89Zr]Zr-BI 754111

ClassificationDiagnostic agent (In vivo) > Radionuclide Imaging agentRadiation-emitting products > Nuclides > Zirconium > 89ZrRadiation-emitting products > Radionuclide Drug Conjugates +[5]

Mechanisms of ActionAnti-Lymphocyte activation gene 3 protein

TargetsLymphocyte activation gene 3 protein

Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungHead and Neck Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryNetherlands

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesVrije Universiteit Amsterdam Cancer Center Amsterdam

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesC.H. Boehringer Sohn Ag & Co. Kg

Active IndicationsN/A

Inactive IndicationsCarcinoma, Non-Small-Cell LungHead and Neck Neoplasms

Other Information

ATC CodeN/A